Correlation Between Amgen and Eli Lilly

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amgen and Eli Lilly at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amgen and Eli Lilly into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amgen Inc and Eli Lilly and, you can compare the effects of market volatilities on Amgen and Eli Lilly and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amgen with a short position of Eli Lilly. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amgen and Eli Lilly.

Diversification Opportunities for Amgen and Eli Lilly

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Amgen and Eli is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Amgen Inc and Eli Lilly and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eli Lilly and Amgen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amgen Inc are associated (or correlated) with Eli Lilly. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eli Lilly has no effect on the direction of Amgen i.e., Amgen and Eli Lilly go up and down completely randomly.

Pair Corralation between Amgen and Eli Lilly

Assuming the 90 days trading horizon Amgen Inc is expected to under-perform the Eli Lilly. But the stock apears to be less risky and, when comparing its historical volatility, Amgen Inc is 1.28 times less risky than Eli Lilly. The stock trades about -0.05 of its potential returns per unit of risk. The Eli Lilly and is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  84,445  in Eli Lilly and on September 23, 2024 and sell it today you would lose (8,025) from holding Eli Lilly and or give up 9.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Amgen Inc  vs.  Eli Lilly and

 Performance 
       Timeline  
Amgen Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amgen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Eli Lilly 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eli Lilly and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Eli Lilly is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Amgen and Eli Lilly Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amgen and Eli Lilly

The main advantage of trading using opposite Amgen and Eli Lilly positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amgen position performs unexpectedly, Eli Lilly can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eli Lilly will offset losses from the drop in Eli Lilly's long position.
The idea behind Amgen Inc and Eli Lilly and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing